mdlinx mdlinx
Rheumatology Articles on MDLinx
Latest (20) Full Text Top Read since last login Focus on Rheumatologic Skin Disorders Article Summary

Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors
Rheumatology, 08/25/2011  Clinical Article

Mackie SL et al. – In GCA, area-level socio-economic deprivation was associated with ischaemic manifestations: this was not mediated by traditional cardiovascular risk factors. These findings are novel and require replication. Delay between first symptoms and treatment may play a role. Public awareness campaigns about GCA should aim especially to engage individuals living in more deprived areas to encourage early presentation and prompt treatment.

Methods

  • Observational study of rheumatologist/ophthalmologist-diagnosed GCA in 8 UK centres
  • Main outcome measure was ischaemic manifestations observed during active GCA: visual loss/blurring, aura, diplopia, jaw/tongue/limb claudication, cerebral/myocardial ischaemia or scalp necrosis

Results
  • Out of 271 patients, 222 had ischaemic manifestations
  • Adjusted ORs for influence of hypertension and atherosclerosis were 1.6 (95% CI 0.8, 3.1) and 1.5 (0.6, 3.5)
  • Most striking finding was an association of ischaemic manifestations with increasing Index of Deprivation 2007 score: OR 4.2 (95% CI 1.3, 13.6) for the most-deprived quartile compared with least-deprived quartile
  • Similar effect sizes were seen within each recruitment centre. Deprivation was associated with smoking and negatively associated with previous polymyalgia
  • Neither of these variables, nor hypertension or atherosclerosis, appeared responsible for mediating effect of deprivation on ischaemic complications
  • Smoking was not associated with ischaemic manifestations
  • Median symptom duration before treatment was 30 days; after adjusting for symptom duration, the OR for ischaemic complications was 3.2 (95% CI 1.0, 10.8) for most-deprived quartile compared with least-deprived quartile

► Link to PubMed, Publisher, See related articles and more ...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

Last month's top read Top 50 of 2011

1 Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis Modern Rheumatology, May 9, 2012    Clinical Article

2 Impact of statin discontinuation on mortality in patients with rheumatoid arthritis - A population-based study Arthritis Care and Research , May 1, 2012    Clinical Article

3 Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Annals of Rheumatic Diseases, May 23, 2012    Clinical Article

4 Association between systemic anti-psoriatic drugs and cardiovascular risk in patients with psoriasis and psoriatic arthritis: A nationwide cohort study Arthritis & Rheumatism, May 4, 2012    Clinical Article

5 Effectiveness of Nigella sativa Oil in the Management of Rheumatoid Arthritis Patients: A Placebo Controlled Study Phytotherapy Research, May 7, 2012    Clinical Article

6 Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol Arthritis & Rheumatism, April 16, 2012    Clinical Article

7 Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis. Results of a 12 month open-label randomized study. Full Text Arthritis Research & Therapy, May 18, 2012    Free full text    Clinical Article

8 Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Annals of Rheumatic Diseases, May 10, 2012    Clinical Article

9 Rilonacept (Interleukin-1 Trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results of the presurge-1 trial Arthritis Care and Research , May 7, 2012    Clinical Article

10 A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early, aggressive rheumatoid arthritis Arthritis & Rheumatism, April 30, 2012    Clinical Article

11 Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) Annals of Rheumatic Diseases, May 10, 2012    Clinical Article

12 Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial Rheumatology, May 21, 2012    Clinical Article

13 Intra-Articular Glucocorticosteroid Injection into Sternocostoclavicular Joints in Patients with SAPHO Syndrome Seminars in Arthritis and Rheumatism, May 8, 2012    Clinical Article

14 Vitamin D and Bone Current Osteoporosis Reports, May 9, 2012    Clinical Article

15 A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Arthritis & Rheumatism, April 24, 2012    Clinical Article

16 Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis Clinical and Experimental Nephrology, April 17, 2012    Clinical Article

17 A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study Modern Rheumatology, May 3, 2012    Clinical Article

18 Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study Arthritis & Rheumatism, April 30, 2012    Clinical Article

19 Evidence-Based Knee Injections for the Management of Arthritis Pain Medicine, May 25, 2012    Evidence Based Medicine    Clinical Article

20 Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohns disease Annals of Rheumatic Diseases, May 24, 2012    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close